These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36201275)

  • 1. The Severity of COVID-19 in Diabetes Patients.
    Danao K; Rokde V; Bali N; Mahajan U
    Curr Diabetes Rev; 2023; 19(5):e061022209633. PubMed ID: 36201275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus and COVID-19: Review Article.
    Nassar M; Daoud A; Nso N; Medina L; Ghernautan V; Bhangoo H; Nyein A; Mohamed M; Alqassieh A; Soliman K; Alfishawy M; Sachmechi I; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102268. PubMed ID: 34562865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing diabetes in diabetic patients with COVID: where do we start from?
    Avogaro A; Bonora B; Fadini GP
    Acta Diabetol; 2021 Nov; 58(11):1441-1450. PubMed ID: 34173070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.
    Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1777-1781. PubMed ID: 32942253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance in COVID-19 and diabetes.
    Govender N; Khaliq OP; Moodley J; Naicker T
    Prim Care Diabetes; 2021 Aug; 15(4):629-634. PubMed ID: 33849817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
    Singh AK; Gupta R; Ghosh A; Misra A
    Diabetes Metab Syndr; 2020; 14(4):303-310. PubMed ID: 32298981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
    Singh AK; Khunti K
    Diabetes Res Clin Pract; 2020 Jul; 165():108266. PubMed ID: 32533989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
    Das S; K R A; Birangal SR; Nikam AN; Pandey A; Mutalik S; Joseph A
    Life Sci; 2020 Oct; 258():118202. PubMed ID: 32758625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
    Samuel SM; Varghese E; Büsselberg D
    Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
    Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M
    J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of diabetes and the prognosis of COVID-19 patients: A retrospective study.
    Liu Z; Bai X; Han X; Jiang W; Qiu L; Chen S; Yu X
    Diabetes Res Clin Pract; 2020 Nov; 169():108386. PubMed ID: 32853685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
    Liu Y; Fu X; Xie C
    Medicine (Baltimore); 2020 Sep; 99(37):e22031. PubMed ID: 32925737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Diabetes in COVID-19 Associated Mucormycosis and its Management: A Non-Systematic Literature Review.
    Rashid M; Rajan AK; Thunga G; Shanbhag V; Nair S
    Curr Diabetes Rev; 2023; 19(3):e240222201411. PubMed ID: 35209828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.
    Barrett CE; Koyama AK; Alvarez P; Chow W; Lundeen EA; Perrine CG; Pavkov ME; Rolka DB; Wiltz JL; Bull-Otterson L; Gray S; Boehmer TK; Gundlapalli AV; Siegel DA; Kompaniyets L; Goodman AB; Mahon BE; Tauxe RV; Remley K; Saydah S
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):59-65. PubMed ID: 35025851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
    Zhang J; Zhang J; Tao Z
    Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the interaction between COVID-19 and diabetes mellitus.
    Chee YJ; Tan SK; Yeoh E
    J Diabetes Investig; 2020 Sep; 11(5):1104-1114. PubMed ID: 32558211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.